UK adds nerve disorder as rare side-effect of AstraZeneca COVID-19 vaccine

The UK drug regulator added an extremely rare nerve-damaging disorder, Guillain-Barré syndrome, or GBS, as a very rare side effect of the AstraZeneca COVID-19 vaccine, updates on the agency's website showed on Thursday.

>>Reuters
Published : 22 Oct 2021, 05:28 AM
Updated : 22 Oct 2021, 05:28 AM

Medicines and Healthcare products Regulatory Agency's decision comes after the European medicines agency added GBS as a possible side-effect last month.